[go: up one dir, main page]

WO2003048385A3 - Structure oligonucleotidique, detection de nucleotides et dispositif associe - Google Patents

Structure oligonucleotidique, detection de nucleotides et dispositif associe Download PDF

Info

Publication number
WO2003048385A3
WO2003048385A3 PCT/EP2002/013861 EP0213861W WO03048385A3 WO 2003048385 A3 WO2003048385 A3 WO 2003048385A3 EP 0213861 W EP0213861 W EP 0213861W WO 03048385 A3 WO03048385 A3 WO 03048385A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligonucleotide array
detection method
field
device therefor
nucleotide detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/013861
Other languages
German (de)
English (en)
Other versions
WO2003048385A2 (fr
Inventor
Stefanie Waschuetza
Alf-Andreas Krehan
Oliver Boecher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Diagnostics GmbH
Original Assignee
Adnagen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adnagen GmbH filed Critical Adnagen GmbH
Priority to AU2002349054A priority Critical patent/AU2002349054A1/en
Priority to EP02781342A priority patent/EP1456406A2/fr
Publication of WO2003048385A2 publication Critical patent/WO2003048385A2/fr
Publication of WO2003048385A3 publication Critical patent/WO2003048385A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Structure oligonucléotidique qui comporte un substrat possédant au moins un champ dans lequel sont immobilisés des oligonucléotides à séquence spécifique de champ. Les oligonucléotides immobilisés d'un (des) champ(s) sont modifiés de manière telle qu'ils sont stables en tant que brin ou unique et / ou en tant que double brin par rapport à une dégradation enzymatique, chimique, physique et / ou physico-chimique.
PCT/EP2002/013861 2001-12-06 2002-12-06 Structure oligonucleotidique, detection de nucleotides et dispositif associe Ceased WO2003048385A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002349054A AU2002349054A1 (en) 2001-12-06 2002-12-06 Oligonucleotide array, nucleotide detection method and device therefor
EP02781342A EP1456406A2 (fr) 2001-12-06 2002-12-06 Structure oligonucleotidique, detection de nucleotides et dispositif associe

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10159904A DE10159904A1 (de) 2001-12-06 2001-12-06 Oligonukleotidanordnung, Verfahren zum Nukleotidnachweis sowie Vorrichtung hierfür
DE10159904.8 2001-12-06

Publications (2)

Publication Number Publication Date
WO2003048385A2 WO2003048385A2 (fr) 2003-06-12
WO2003048385A3 true WO2003048385A3 (fr) 2004-04-08

Family

ID=7708229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/013861 Ceased WO2003048385A2 (fr) 2001-12-06 2002-12-06 Structure oligonucleotidique, detection de nucleotides et dispositif associe

Country Status (4)

Country Link
EP (1) EP1456406A2 (fr)
AU (1) AU2002349054A1 (fr)
DE (1) DE10159904A1 (fr)
WO (1) WO2003048385A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006296279A (ja) * 2005-04-20 2006-11-02 Sony Corp インターカレーターを用いるハイブリダイゼーション検出方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002258A1 (fr) * 1990-07-27 1992-02-20 Isis Pharmaceuticals, Inc. Oligonucleotides, a pyrimidine modifiee et resistants a la nuclease, detectant et modulant l'expression de genes
WO2000053616A2 (fr) * 1999-03-09 2000-09-14 Amersham Pharmacia Biotech Uk Ltd Immobilisation de polynucleotides
EP1077264A2 (fr) * 1999-06-07 2001-02-21 Fuji Photo Film Co., Ltd. Puce d'ADN, puce d'APN, et des procédés de préparation
WO2001016152A2 (fr) * 1999-09-02 2001-03-08 Amersham Pharmacia Biotech, Inc. Procede d'ancrage d'oligonucleotides a un substrat
WO2001018015A1 (fr) * 1999-09-10 2001-03-15 Geron Corporation Thiophosphoramidates n3'→p5' oligonucleotidiques: synthese et utilisation
WO2001079249A2 (fr) * 2000-04-18 2001-10-25 Aventis Pharma Deutschland Gmbh Polyamidnukleinsaure-derivate, mittel und verfahren zu ihrer herstellung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
EP0558740B1 (fr) * 1991-09-19 1998-08-05 VYSIS, Inc. Composition de sondage destinee a l'identification de genomes, et procedes associes
EP1044987B1 (fr) * 1991-12-24 2006-02-15 Isis Pharmaceuticals, Inc. Oligonucléotides modifiés en 2' à ouverture
DE4338704A1 (de) * 1993-11-12 1995-05-18 Hoechst Ag Stabilisierte Oligonucleotide und deren Verwendung
DE19633436A1 (de) * 1996-08-20 1998-02-26 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Nukleinsäuren unter Ermittlung der Masse
EP1060266A4 (fr) * 1998-02-23 2004-09-22 Dana Farber Cancer Inst Inc Procede permettant d'identifier les sites reactifs des glycosylases de reparation des mesappariements, compose et utilisations de ce dernier
DE10010282B4 (de) * 2000-02-25 2006-11-16 Epigenomics Ag Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben
DE10021204A1 (de) * 2000-04-25 2001-11-08 Epigenomics Ag Verfahren zur hochparallelen Analyse von Polymorphismen

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002258A1 (fr) * 1990-07-27 1992-02-20 Isis Pharmaceuticals, Inc. Oligonucleotides, a pyrimidine modifiee et resistants a la nuclease, detectant et modulant l'expression de genes
WO2000053616A2 (fr) * 1999-03-09 2000-09-14 Amersham Pharmacia Biotech Uk Ltd Immobilisation de polynucleotides
EP1077264A2 (fr) * 1999-06-07 2001-02-21 Fuji Photo Film Co., Ltd. Puce d'ADN, puce d'APN, et des procédés de préparation
WO2001016152A2 (fr) * 1999-09-02 2001-03-08 Amersham Pharmacia Biotech, Inc. Procede d'ancrage d'oligonucleotides a un substrat
WO2001018015A1 (fr) * 1999-09-10 2001-03-15 Geron Corporation Thiophosphoramidates n3'→p5' oligonucleotidiques: synthese et utilisation
WO2001079249A2 (fr) * 2000-04-18 2001-10-25 Aventis Pharma Deutschland Gmbh Polyamidnukleinsaure-derivate, mittel und verfahren zu ihrer herstellung

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GRYAZNOV S.M. ET AL.: "Oligonucleotide N3' fwdarw P5' phosphoramidates", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 92, no. 13, 1995, 1995, pages 5798 - 5802, XP002258684, ISSN: 0027-8424 *
NIEMEYER C M ET AL: "DNA MICROARRAYS", ANGEWANDTE CHEMIE INTL. ED., vol. 38, no. 19, 1999, pages 302865 - 2869, XP000961724, ISSN: 0044-8249 *
PIRRUNG M.C.: "SPATIALLY ADDRESSABLE COMBINATORIAL LIBRARIES", CHEMICAL REVIEWS, AMERICAN CHEMICAL SOCIETY, vol. 97, no. 2, 1 March 1997 (1997-03-01), pages 473 - 488, XP000683276, ISSN: 0009-2665 *
PONGRACZ K. ET AL.: "Oligonucleotide N3'->P5' thiophosphoramidates: synthesis and properties", TETRAHEDRON LETTERS, vol. 40, no. 43, 22 October 1999 (1999-10-22), pages 7661 - 7664, XP004179889, ISSN: 0040-4039 *
STEIN C.A. ET AL.: "ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL?", SCIENCE, vol. 261, 20 August 1993 (1993-08-20), pages 1004 - 1012, XP000579110, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
DE10159904A1 (de) 2003-07-03
EP1456406A2 (fr) 2004-09-15
WO2003048385A2 (fr) 2003-06-12
AU2002349054A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
WO2003100017A3 (fr) Oligonucleotides a unites nucleosides modifiees
WO2004092191A3 (fr) Promedicaments oligonucleotidiques polymeres
WO2004013280A3 (fr) Silençage genique a mediation par arnsi specifique des alleles
WO2005120230A3 (fr) Produits de synthese d'arnsi modifies en position
WO2006002038A3 (fr) Multimeres d'oligonucleotides immunostimulateurs
WO2002026967A3 (fr) Correction de gene cible au moyen d'oligodesoxynucleotides monocatenaires
WO2001034842A3 (fr) Amplification en chaine par polymerase (pcr) sur des microarrangements d'oligonucleotides immobilises par un gel
EP1229134A3 (fr) Utilisation de l'inhibition post-transcriptionnelle pour l'identification des séquences d'acides nucléiques qui modifient la fonction d'une cellule
WO2003039523A3 (fr) Oligonucleotides modifies a l'aide de nouveaux analogues d'arn-l-alpha
WO2002006531A3 (fr) Sondes d'acides nucleiques a structure en epingle a cheveux et utilisations associees
WO2001088173A3 (fr) Procedes d'assemblage enzymatique de polynucleotides et identification de polynucleotides possedant des caracteristiques souhaitees
EP0969282A3 (fr) Un électrode d'enzymes, un biocapteur et un dispositif de mesure en conséquence
WO2007120208A3 (fr) Séquençage de l'adn en cercle tournant sur nanogrille
EP2258847A3 (fr) Autres nouvelles formes de molécules d'ARN interférant
WO2003052132A3 (fr) Analogues d'oligonucleotides lineaires et en epingle a cheveux comprenant des pseudonucleotides intercalants
WO2005040419A8 (fr) Jeu ordonne de microechantillons oligonucleotidiques
WO2003012124A3 (fr) Methodes pour immobiliser des molecules sur une phase solide et leurs utilisations
WO2005054270A3 (fr) Identification et conception de molecule arnsi
WO2003050240A3 (fr) Systeme d'expression
WO2006045591A3 (fr) Procede et produits de synthese permettant d'administrer un arn en double brin a des organismes de parasites
AU2003218868A1 (en) Microarray devices having controllable reaction volume
AU2002346517A1 (en) Thermus oshimai nucleic acid polymerases
WO2003048385A3 (fr) Structure oligonucleotidique, detection de nucleotides et dispositif associe
WO2006125447A3 (fr) Formation stable et selective de triplexes et de duplexes de type hoogsteen au moyen d'acides nucleiques intercalants tordus (tina) et procede de preparation de tina
WO2007048244A3 (fr) Petits oligonucleotides interferents comprenant des nucleotides a arabinose modifie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002781342

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002781342

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002781342

Country of ref document: EP